News


Follow Us

To stay abreast of the
latest developments at
our fast-moving company,
please follow us on
Twitter, LinkedIn, and
Facebook:

    

  • Genome Sequence of Klebsiella pneumoniae Respiratory Isolate IA565 Published Using Accel-NGS™ 2S DNA Library Kit

    Genome Announcements - 11-Sep-2014

    Investigators at the University of Michigan have published the sequence of the K. pneumoniae strain IA565 using libraries prepared with the Accel-NGS™ 2S DNA Library Kit for Illumina.

    Read the full article

    Genome Sequence of Klebsiella pneumoniae Respiratory Isolate IA565 Published Using Accel-NGS™ 2S DNA Library Kit

    Genome Announcements - 11-Sep-2014

  • Genome Sequence of Klebsiella pneumoniae Urinary Tract Isolate Top52 Published Using Accel-NGS™ 2S DNA Library Kit

    Genome Announcements - 3-Jul-2014

    Investigators at the University of Michigan have published the sequence of the K. pneumoniae strain TOP52 #1721 using libraries prepared with the Accel-NGS™ 2S DNA Library Kit for Illumina.

    Read the full article

    Genome Sequence of Klebsiella pneumoniae Urinary Tract Isolate Top52 Published Using Accel-NGS™ 2S DNA Library Kit

    Genome Announcements - 3-Jul-2014

  • Swift Biosciences Launches Accel-NGS™ 2S DNA Library Kit

    Press Release - Ann Arbor, MI - 03-Mar-2014

    Incorporating patent-pending technology, the Swift “2S” kit provides linear yields from inputs ranging from 10 pg to 1 µg. PCR-free libraries can be produced from as little as 100 ng. Unlike other commercially available kits, exceptional quality and evenness of coverage are obtained even at very low levels of DNA input. The product is also ideally suited for clinical samples such as FFPE tissues and plasma.

    Read the full article

    Swift Biosciences Launches Accel-NGS™ 2S DNA Library Kit

    Press Release - Ann Arbor, MI - 03-Mar-2014

  • Genome Sequences of C. jejuni Variants Published Using Accel-NGS™ DNA Library Kit for Ion Torrent

    Genome Announcements - 06-Feb-2014

    Investigators at the University of Michigan have published the sequences of three C. jejuni strains using libraries prepared with the Accel-NGS™ DNA Library Kit for Ion Torrent.

    Read the full article

    Genome Sequences of C. jejuni Variants Published Using Accel-NGS™ DNA Library Kit for Ion Torrent

    Genome Announcements - 06-Feb-2014

  • Swift Biosciences, Inc. Announces the Launch of Accel-NGS™ PCR-free DNA Library Kit for Illumina

    Press Release - Ann Arbor, MI - 11-Nov-2013

    Swift Biosciences, Inc. today announced the launch of the Accel-NGS™ PCR-free DNA Library Kit for Illumina Next Generation Sequencing (NGS) systems. This launch follows the successful launch earlier this year of a similar product for use on Ion Torrent platforms. Swift’s new kit is designed to bring the same benefits - low input requirement, PCR-free capability and fast, easy workflow - to the Illumina platform.

    Read the full article

    Swift Biosciences, Inc. Announces the Launch of Accel-NGS™ PCR-free DNA Library Kit for Illumina

    Press Release - Ann Arbor, MI - 11-Nov-2013

  • Swift Biosciences Announces $7 Million Series B Financing

    Press Release - Ann Arbor, MI - 17-Oct-2013

    Swift Biosciences, Inc., a Michigan-based life sciences company, today announced the recent completion of a $7 million Series B financing led by Fletcher Spaght Ventures. Also joining in the B round of investment was Renaissance Venture Capital Fund and the Series A investors, including the Mercury Fund, Michigan Accelerator Fund and several Michigan-based individual investors.

    Read the full article

    Swift Biosciences Announces $7 Million Series B Financing

    Press Release - Ann Arbor, MI - 17-Oct-2013

  • Swift Biosciences Announces Early Access Program for Accel-NGS™ DNA Library Kit for Illumina

    Press Release - Ann Arbor, MI - 26-Jun-2013

    Swift Biosciences, Inc. today announced an Early Access Program for the Accel-NGS™ DNA Library Kit for Illumina Next Generation Sequencing (NGS) systems.

    Read the full article

    Swift Biosciences Announces Early Access Program for Accel-NGS™ DNA Library Kit for Illumina

    Press Release - Ann Arbor, MI - 26-Jun-2013

  • Swift Biosciences Introduces Accel-NGS™ DNA Library Kit

    Press Release - Ann Arbor, MI - 27-Feb-2013

    Swift Biosciences, Inc. today announced the launch of the Accel-NGS™ DNA Library Kit, the first product in a new line of kits for Next Generation Sequencing (NGS) sample preparation. NGS users can now produce PCR-free libraries with as little as 5 ng of input DNA.

    Read the full article

    Swift Biosciences Introduces Accel-NGS™ DNA Library Kit

    Press Release - Ann Arbor, MI - 27-Feb-2013

  • Michigan Accelerator Fund I Invests $750,000 in Swift Biosciences

    Press Release - Grand Rapids, MI - 15-Jan-2013

    Michigan Accelerator Fund I (MAF‐1) has made a $750,000 Series A‐1 investment in Swift Biosciences, Inc. This is the seventh company MAF‐1 has funded since the fund’s inception in 2010, and the first investment since the fund closed at $15.1M in August of 2012.

    Read the full article

    Michigan Accelerator Fund I Invests $750,000 in Swift Biosciences

    Press Release - Grand Rapids, MI - 15-Jan-2013

  • Swift Biosciences Signs Technology License Agreement with VelaDx

    Press Release - Ann Arbor, MI - 03-Dec-2012

    Swift Biosciences, Inc. today announced that it has signed a technology license agreement with Vela Operations Pte. Ltd, the Singapore-based parent of Vela Diagnostics. The agreement gives Vela non-exclusive rights to utilize Swift’s myT® Primer technology in Vela’s real-time quantitative PCR-based IVD products for the detection of somatic mutations in human cancer.

    Read the full article

    Swift Biosciences Signs Technology License Agreement with VelaDx

    Press Release - Ann Arbor, MI - 03-Dec-2012

  • Swift Biosciences Covered in GenomeWeb's PCR Insider Product Watch

    GenomeWeb - 27-Sep-2012

    Swift Biosciences has announced a new addition to its line of myT Primer reagents to detect key cancer mutations.

    Read the full article

    Swift Biosciences Covered in GenomeWeb's PCR Insider Product Watch

    GenomeWeb - 27-Sep-2012

  • Swift Biosciences Introduces myT® BRAF-Ultra

    Press Release - Ann Arbor, MI - 17-Sep-2012

    Swift Biosciences, Inc. has announced a new addition to its line of myT® Primer reagents for the detection of key cancer mutations. myT BRAF-Ultra, an ultrasensitive version of myT BRAF, provides 0.01% sensitivity down to single copy detection of BRAF mutations and is now available from Swift.

    Read the full article

    Swift Biosciences Introduces myT® BRAF-Ultra

    Press Release - Ann Arbor, MI - 17-Sep-2012

  • Swift Biosciences Launches BRAF Mutation Assay; Tacks on $2.4M to Series A Financing Round

    GenomeWeb - 23-Feb-2012

    "Swift Biosciences this week announced the formal commercial launch of its first product, a BRAF mutation-detection assay based on the company's proprietary "myT Primer" qPCR reagents."

    Read the full article

    Swift Biosciences Launches BRAF Mutation Assay; Tacks on $2.4M to Series A Financing Round

    GenomeWeb - 23-Feb-2012

  • Swift Biosciences Introduces myT™ BRAF

    Press Release - Ann Arbor, MI - 20-Feb-2012

    Swift Biosciences, Inc. today announced their new line of myT™ Primer reagents for the detection of key cancer mutations.

    Read the full article

    Swift Biosciences Introduces myT™ BRAF

    Press Release - Ann Arbor, MI - 20-Feb-2012

  • Swift Biosciences Covered in Crain's Detroit Business

    Crain's Detroit Business - 12-Feb-2012

    "David Olson grew up as a nature lover, not exactly on a path to commercialize research used in the fight against cancer.

    Yet that's where this entrepreneur has landed, most recently as the founder of Ann Arbor-based Swift Biosciences Inc. The company develops molecular biology reagents for research and diagnostic applications, and its technologies offer new ways to examine disease-related genes and enable tools for managing cancer."

    Read the full article

    Swift Biosciences Covered in Crain's Detroit Business

    Crain's Detroit Business - 12-Feb-2012

  • Swift Biosciences Adds Senior Executive for Commercialization

    Press Release - Ann Arbor, MI - 10-Mar-2011

    Swift Biosciences Inc. today announced that Steve Spotts has joined the company as Chief Commercial Officer.

    Read the full article

    Swift Biosciences Adds Senior Executive for Commercialization

    Press Release - Ann Arbor, MI - 10-Mar-2011

  • Swift Biosciences Unveils qPCR Primer Tech; Hopes to Market First Product by Year's End

    GenomeWeb - 24-Feb-2011

    "Swift this week publicly presented the first research results for its core technology, a new kind of highly sensitive qPCR primer designed for mutation and low copy number detection, and said it would eventually market products in the research, diagnostics, and next-generation sequencing spaces."

    Read the full article

    Swift Biosciences Unveils qPCR Primer Tech; Hopes to Market First Product by Year's End

    GenomeWeb - 24-Feb-2011

  • Swift Biosciences Announces Performance Data for Mutation Detection

    Press Release - San Francisco, CA - 23-Feb-2011

    Swift Biosciences Inc., a developer of innovative genetic analysis tools for the research and diagnostic markets, today presented at the 18th International Molecular Medicine Tri-Conference their high performance qPCR myT™ Primers for highly sensitive, highly specific detection of cancer mutations.

    Read the full article

    Swift Biosciences Announces Performance Data for Mutation Detection

    Press Release - San Francisco, CA - 23-Feb-2011

  • Swift Biosciences Announces $3M Series A

    Press Release - Ann Arbor, MI - 10-Aug-2010

    Swift Biosciences Inc., a Michigan-based life sciences company, today announced the recent completion of a $3 million Series A financing led by the venture firm DFJ Mercury. DFJ Mercury was joined in the Series A by several Michigan-based individual investors who also helped launch the Company with seed funding in January 2010.

    Read the full article

    Swift Biosciences Announces $3M Series A

    Press Release - Ann Arbor, MI - 10-Aug-2010